Literature DB >> 3100915

Characterization of purified Shiga toxin from Shigella dysenteriae 1.

T Yutsudo, T Honda, T Miwatani, Y Takeda.   

Abstract

Shiga toxin was purified from the culture supernatant of Shigella dysenteriae 1 by ammonium sulfate fractionation, DEAE-cellulose column chromatography and repeated chromatofocusing column chromatography. About 1.6 mg of purified Shiga toxin was obtained from 15 liters of culture with a yield of about 27%. The molecular weight of purified Shiga toxin was estimated to be 62,000. The toxin consisted of A and B subunits with molecular weights of about 30,000 and 5,000-6,000, respectively. The isoelectric point of purified Shiga toxin was 7.0. Purified Shiga toxin showed the following biological activities: lethal toxicity to mice when injected intraperitoneally with an LD50 of 28 ng per mouse; cytotoxicity to Vero cells, killing about 50% of the cells at 1 pg and all of the cells at 10 pg; and fluid accumulation in rabbit ileal loops at a concentration of more than 1 microgram.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3100915     DOI: 10.1111/j.1348-0421.1986.tb03041.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  7 in total

1.  Purification and characterization of an Escherichia coli Shiga-like toxin II variant.

Authors:  D L MacLeod; C L Gyles
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

2.  Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin.

Authors:  U Kongmuang; T Honda; T Miwatani
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

Review 3.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

4.  Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.

Authors:  Daniel Steil; Catherine-Louise Schepers; Gottfried Pohlentz; Nadine Legros; Jana Runde; Hans-Ulrich Humpf; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2015-10-13       Impact factor: 5.922

5.  Novel cholix toxin variants, ADP-ribosylating toxins in Vibrio cholerae non-O1/non-O139 strains, and their pathogenicity.

Authors:  Sharda Prasad Awasthi; Masahiro Asakura; Nityananda Chowdhury; Sucharit Basu Neogi; Atsushi Hinenoya; Hossain M Golbar; Jyoji Yamate; Eiji Arakawa; Toshiji Tada; T Ramamurthy; Shinji Yamasaki
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

6.  Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome.

Authors:  S Yamada; A Kai; Y Kudoh
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

Review 7.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.